EXPEDITED REVIEW
Autologous Bone Marrow Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor After Subacute ST-Segment Elevation Myocardial Infarction Undergoing Late Revascularization
Final Results From the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) Trial
Markus G. Engelmann, MD*,
Hans D. Theiss, MD*,
Christine Hennig-Theiss*,
Armin Huber, MD ,
Bernd J. Wintersperger, MD,
Anja-Eva Werle-Ruedinger,
Stefan O. Schoenberg, MD,
Gerhard Steinbeck, MD* and
Wolfgang-M. Franz, MD*,*
* Medical Clinic I—Department of Cardiology, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany
Department of Clinical Diagnostic Radiology, Ludwig Maximilians University, Klinikum Grosshadern, Munich, Germany
Manuscript received January 20, 2006;
revised manuscript received June 29, 2006,
accepted July 3, 2006.
* Reprint requests and correspondence: Prof. Dr. med. Wolfgang-M. Franz, Ludwig Maximilians University, Medical Clinic I—Department of Cardiology Klinikum Grosshadern, Marchioninistr. 15, D-81377 Munich, Germany. (Email: wolfgang.franz{at}med.uni-muenchen.de).
OBJECTIVES: The purpose of this investigator-driven, prospective, randomized, double-blinded, placebo-controlled phase II study was to compare the effects of granulocyte colony-stimulating factor (G-CSF) on the improvement of myocardial function in patients undergoing delayed percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI).
BACKGROUND: Experimental and early clinical studies suggest that transplantation of stem cells improves cardiac regeneration and neovascularization after acute myocardial infarction. Most investigators have utilized either a direct injection or intracoronary infusion of bone marrow–derived cells, but early cytokine-mediated mobilization of stem cells has been reported to show similar improvement in cardiac function.
METHODS: Forty-four patients with late revascularized subacute STEMI were treated either with G-CSF or placebo over 5 days after successful PCI. Primary end points were change of global and regional myocardial function from baseline (1 week after PCI) to 3 months after PCI assessed by magnetic resonance imaging (MRI). Secondary end points consisted of characterization of mobilized stem cell populations, assessment of safety parameters up to 12 months including 6-month angiography, as well as myocardial perfusion assessed by MRI.
RESULTS: Global myocardial function from baseline (1 week after PCI) to 3 months improved in both groups, but G-CSF was not superior to placebo ( ejection fraction 6.2 ± 9.0 vs. 5.3 ± 9.8%, p = 0.77). A slight but non-significant improvement of regional function occurred in both groups. Granulocyte colony-stimulating factor resulted in mobilization of endothelial progenitor cell populations and was well tolerated with a similar rate of target lesion revascularization from in-stent restenosis. In both groups major adverse cardiovascular events occurred in a comparable frequency. Granulocyte colony-stimulating factor resulted in significant improvement of myocardial perfusion 1 week and 1 month after PCI.
CONCLUSIONS: Granulocyte colony-stimulating factor treatment after PCI in subacute STEMI is feasible and relatively safe. However, patients do not benefit from G-CSF when PCI is performed late. Granulocyte colony-stimulating factor results in improved myocardial perfusion of the infarcted area, which may reflect enhanced neovascularization.
|
Abbreviations and Acronyms
| | EF = ejection fraction | | FIRSTLINE-AMI = Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor Trial | | G-CSF = granulocyte colony-stimulating factor | | ISR = in-stent restenosis | | MACE = major adverse cardiovascular events | | MI = myocardial infarction | | MRI = magnetic resonance imaging | | PCI = percutaneous coronary intervention | | STEMI = ST-segment elevation myocardial infarction | | TLR = target lesion revascularization |
|
Related Article
-
Myocardial Regeneration by Stem Cells: Seeing the Unseeable
- James S. Forrester, Prediman K. Shah, and Raj R. Makkar
J. Am. Coll. Cardiol. 2006 48: 1722-1724.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S. Brunner, T. Weinberger, B. C. Huber, A. Segeth, M.-M. Zaruba, H. D. Theiss, G. Assmann, N. Herbach, R. Wanke, J. Mueller-Hoecker, et al.
The cardioprotective effects of parathyroid hormone are independent of endogenous granulocyte-colony stimulating factor release
Cardiovasc Res,
February 1, 2012;
93(2):
330 - 339.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Wang, J. Takagawa, V. C. Lam, D. J. Haddad, D. L. Tobler, P. Y. Mok, Y. Zhang, B. T. Clifford, K. Pinnamaneni, S. A. Saini, et al.
Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response
Science Translational Medicine,
September 14, 2011;
3(100):
100ra90 - 100ra90.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C. Huber, S. Brunner, A. Segeth, P. Nathan, R. Fischer, M. M. Zaruba, M. Vallaster, H. D. Theiss, R. David, A. Gerbitz, et al.
Parathyroid hormone is a DPP-IV inhibitor and increases SDF-1-driven homing of CXCR4+ stem cells into the ischaemic heart
Cardiovasc Res,
June 1, 2011;
90(3):
529 - 537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Shim, A. Mehta, S. Y. Lim, G. Zhang, C. H. Lim, T. Chua, and P. Wong
G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?
Cardiovasc Res,
January 1, 2011;
89(1):
20 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Beohar, J. Rapp, S. Pandya, and D. W. Losordo
Rebuilding the Damaged Heart: The Potential of Cytokines and Growth Factors in the Treatment of Ischemic Heart Disease
J. Am. Coll. Cardiol.,
October 12, 2010;
56(16):
1287 - 1297.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Achilli, C. Malafronte, L. Lenatti, F. Gentile, V. Dadone, G. Gibelli, S. Maggiolini, L. Squadroni, C. Di Leo, I. Burba, et al.
Granulocyte colony-stimulating factor attenuates left ventricular remodelling after acute anterior STEMI: results of the single-blind, randomized, placebo-controlled multicentre STem cEll Mobilization in Acute Myocardial Infarction (STEM-AMI) Trial
Eur J Heart Fail,
October 1, 2010;
12(10):
1111 - 1121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Janssens
Granulocyte colony-stimulating factor in cardiac repair: time for a reappraisal?
Eur J Heart Fail,
October 1, 2010;
12(10):
1021 - 1023.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C. Huber, R. Fischer, S. Brunner, M. Groebner, C. Rischpler, A. Segeth, M. M. Zaruba, T. Wollenweber, M. Hacker, and W. M. Franz
Comparison of parathyroid hormone and G-CSF treatment after myocardial infarction on perfusion and stem cell homing
Am J Physiol Heart Circ Physiol,
May 1, 2010;
298(5):
H1466 - H1471.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Hiraumi, E. Iwai-Kanai, S. Baba, Y. Yui, Y. Kamitsuji, Y. Mizushima, H. Matsubara, M. Watanabe, K.-i. Watanabe, S. Toyokuni, et al.
Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury
Am J Physiol Heart Circ Physiol,
March 1, 2009;
296(3):
H823 - H832.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Brunner, J. Winogradow, B. C. Huber, M.-M. Zaruba, R. Fischer, R. David, G. Assmann, N. Herbach, R. Wanke, J. Mueller-Hoecker, et al.
Erythropoietin administration after myocardial infarction in mice attenuates ischemic cardiomyopathy associated with enhanced homing of bone marrow-derived progenitor cells via the CXCR-4/SDF-1 axis
FASEB J,
February 1, 2009;
23(2):
351 - 361.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Menasche
Chapter 10 Stem Cell Therapy Post-AMI
Cardiac Protection,
January 1, 2009;
1(1):
med-9780199544769-chapter - med-9780199544769-chapter.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
Z. Cheng, L. Ou, Y. Liu, X. Liu, F. Li, B. Sun, Y. Che, D. Kong, Y. Yu, and G. Steinhoff
Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion
Cardiovasc Res,
December 1, 2008;
80(3):
425 - 434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Valgimigli, G. G.L. Biondi-Zoccai, P. Malagutti, A. M. Leone, and A. Abbate
Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after myocardial infarction
Eur. Heart J. Suppl.,
December 1, 2008;
10(suppl_K):
K27 - K34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S-A Chang, H-K Kim, H-Y Lee, S-Y Choi, B-K Koo, Y-J Kim, D-W Sohn, B-H Oh, Y-B Park, Y-S Choi, et al.
Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction
Heart,
August 1, 2008;
94(8):
995 - 1001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Hinkel, C. El-Aouni, T. Olson, J. Horstkotte, S. Mayer, S. Muller;, M. Willhauck, C. Spitzweg, F.-J. Gildehaus, W. Munzing, et al.
Thymosin {beta}4 Is an Essential Paracrine Factor of Embryonic Endothelial Progenitor Cell-Mediated Cardioprotection
Circulation,
April 29, 2008;
117(17):
2232 - 2240.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Zohlnhofer, A. Dibra, T. Koppara, A. de Waha, R. S. Ripa, J. Kastrup, M. Valgimigli, A. Schomig, and A. Kastrati
Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction: A Meta-Analysis
J. Am. Coll. Cardiol.,
April 15, 2008;
51(15):
1429 - 1437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-M. Zaruba, B. C. Huber, S. Brunner, E. Deindl, R. David, R. Fischer, G. Assmann, N. Herbach, S. Grundmann, R. Wanke, et al.
Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival
Cardiovasc Res,
March 1, 2008;
77(4):
722 - 731.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Kip, K. Hollabaugh, O. C. Marroquin, and D. O. Williams
The Problem With Composite End Points in Cardiovascular Studies: The Story of Major Adverse Cardiac Events and Percutaneous Coronary Intervention
J. Am. Coll. Cardiol.,
February 19, 2008;
51(7):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Brunner, H. D. Theiss, A. Murr, T. Negele, and W.-M. Franz
Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells
Am J Physiol Endocrinol Metab,
December 1, 2007;
293(6):
E1670 - E1675.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. K. Hammond
Skeletal Muscle-Derived Stem Cell Transplantation: Angiogenesis Is Required for Improved Left Ventricular Function
J. Am. Coll. Cardiol.,
October 23, 2007;
50(17):
1685 - 1687.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Ripa, M. Haack-Sorensen, Y. Wang, E. Jorgensen, S. Mortensen, L. Bindslev, T. Friis, and J. Kastrup
Bone Marrow Derived Mesenchymal Cell Mobilization by Granulocyte-Colony Stimulating Factor After Acute Myocardial Infarction: Results From the Stem Cells in Myocardial Infarction (STEMMI) Trial
Circulation,
September 11, 2007;
116(11_suppl):
I-24 - I-30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol.,
September 4, 2007;
50(10):
988 - 1003.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol.,
July 17, 2007;
50(3):
270 - 285.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Forrester, P. K. Shah, and R. R. Makkar
Myocardial Regeneration by Stem Cells: Seeing the Unseeable
J. Am. Coll. Cardiol.,
October 17, 2006;
48(8):
1722 - 1724.
[Full Text]
[PDF]
|
|
|
|
